ArticleBritish journal of haematology2017

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.

Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.